Blessed to spend the day with several Oncologist across Texas in congressional offices of @SenTedCruz and @JohnCornyn and many Reps @ASCOadvocacy
Discussed Senior Act concerning preauthorization relief, sustaining Telehealth flexibilities, supporting cancer research funding!
Ray Page, DO PhD retweeted
Honored to have a great visit with Rep Julie Johnson from Dallas in DC and establish a relationship!
Discussed Senior Act concerning preauthorization relief, sustaining Telehealth flexibilities, supporting cancer research funding!
Got to reconnect with brother Pete Sessions in DC for congressional visit @ASCOadvocacy
Discussed Senior Act concerning preauthorization relief, sustaining Telehealth flexibilities, supporting cancer research funding!
Honored to have a great visit with Rep Julie Johnson from Dallas in DC and establish a relationship!
Discussed Senior Act concerning preauthorization relief, sustaining Telehealth flexibilities, supporting cancer research funding!
Ray Page, DO PhD retweeted
Team Texas is ready for the #ASCOAdvocacySummit! We are asking to prioritize federal research funding, #FixPriorAuth, and help end #drugshortages.
Ray Page, DO PhD retweeted
The delegation from @ASCO had a terrific interim meeting w/ @AmerMedicalAssn HOD. We made headway on drug shortages, patient access concerns, & other key resolutions. #ASCOadvocacy #advocacy #whywefight
Texas Society of Clinical Oncology @OSSatACCC was honored to be engaged with Robin Zon MD, FACP, FASCO @ASCOPres at our annual meeting in San Antonio
Thank you brother @PeteSessions for catching up today. Always a pleasure.
We are asking to:
1️⃣ End shortages of life saving drugs
2️⃣ Support @NIH, NCI, & @ARPA_H funding
3️⃣ Make telemedicine permanent
#ASCOAdvocacySummit
Hard working @ASCO delegation to the AMA. We were 3/3 with adoption of ASCO sponsored resolutions regarding AMA advocacy for access to clinical trials for MEDICARE advantage patients, modernizing remote digital lab access under CLIA, and managing ERISA laws with PBMs
Representing Texas @asco State Affiliates Council, with Pennsylvania representative, the great Ed Balaban, DO, good friend and years serving together at AMA HOD. Great meeting at ASCO HQ
It was a pleasure to speak on “Individualized Pathways in Oncology Treatment: Not an Oxymoron” at the Clinical Pathways Congress + Cancer Care Business Exchange in Boston
Very pleased to support my resident, Dr. Joseph Kim, on his poster presentation at TxSCO @OSSatACCC
Was so excited to be on stage interviewing an All Star team on workforce issues and clinician well being in oncology @todd_ap
Thanks to @OSSatACCC #TxSCO Dr Ray Page for invitation to discuss @ASCO Well-being TF efforts, #burnout, & navigating #oncology workforce issues with Dr Gallagher & @todd_ap @ASCOPres @CliffordHudis @waltbirch @MDAndersonNews @UCCancerCenter
Ray Page, DO PhD retweeted
Drs @RayPageDOPhD & @BarbaraMcAneny speaking on behalf of @ASCO at @AmerMedicalAssn #AMAHOD regarding biosimilar therapies for pts w cancer as well as chronic illnesses requiring such therapies. #patientsfirst
Ray Page, DO PhD retweeted
Working together at cancer caucus this am discussing resolutions brought forth by @asco today. Proud of our group- working to influence policy to benefit pts w cancer. #fixpriorauth #biosimilars #clinicaltrials #fixmedicare @AmerMedicalAssn #AMA23
Ray Page, DO PhD retweeted
Replying to @RayPageDOPhD
@RayPageDOPhD presenting the @ASCO-supported resolution for ensuring @MedicareGov advantage coverage for routine care costs for pts on clinical trials. Pts first, always. #amamtg #ama23 @AmerMedicalAssn – at Chicago, IL
Ray Page, DO PhD retweeted
At the #ASCOAdvocacySummit with many of the ASCO Delegates to AMA.
1. fix prior authorization
2. Get rid of copay accumulators
3. Fund cancer research

























